WebFeb 27, 2024 · The Investor Relations website contains information about Inari Medical, Inc.'s business for stockholders, potential investors, and financial analysts. Skip to main … WebApr 13, 2024 · IRVINE, Calif., April 13, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, announced today that it will release its first quarter 2024 financial results on Wednesday, May 3, 2024.

Inari to Bring Growers Proprietary GM Traits in Tandem with

WebApr 13, 2024 · IRVINE, Calif., April 13, 2024 (GLOBE NEWSWIRE) — Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, announced today that it will release its first quarter 2024 financial results on Wednesday, May 3, 2024.In conjunction … WebOct 4, 2024 · CAMBRIDGE, Mass., October 4, 2024 — Inari today announced that it secured $124 million in the successful completion of its latest fundraise. Working to deliver nature … shy 145

Inari Medical to Announce First Quarter 2024 Financial Results

WebOct 4, 2024 · CAMBRIDGE, Mass., Oct. 4, 2024 /PRNewswire/ -- Inari today announced that it secured $124 million in the successful completion of its latest fundraise. Working to … WebMar 21, 2024 · INARI MEDICAL, INC. : Press releases relating to INARI MEDICAL, INC. Investor relations Nasdaq: NARI Nasdaq WebMar 17, 2024 · IRVINE, Calif., March 06, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, announced positive results from the FLAME study in high-risk/massive pulmonary embolism (“PE”). shy 1 hour